Ocular Hypertension (OH): Clinical Trials

7 trials for Ocular Hypertension (OH), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 active not recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Completed 1
Phase 11Active not recruiting 1
Phase 31Recruiting 1

Follow Ocular Hypertension (OH): new trials by email Literature Review of Ocular Hypertension (OH) trials Research Report on Ocular Hypertension (OH)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Bimatoprost ophthalmic solution 0.01% YSBP, bimatoprost ophthalmic solution 0.01% (LumiganĀ®) - Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OH)
Phase 3RecruitingYS Life Science Co., Ltd.6002026-06-022026-09-23
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Travoprost - Open Angle Glaucoma (OAG), Ocular Hypertension (OH)
RecruitingGlaukos Corporation302025-12-172026-02-27
Transscleral Selective Laser Trabeculoplasty Project
Selective Laser Trabeculoplasty - Glaucoma,Open-Angle, Ocular Hypertension (OH)
Not applicableCompletedLumibird Medical (Quantel Medical, Ellex Medical, Optotek)152025-06-192026-08-10
Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension
PA5436 Ocular Implant, 115mcg - Open Angle Glaucoma (OAG), Ocular Hypertension (OH)
Phase 1Active not recruitingPolyActiva Pty Ltd122025-06-102026-07-07
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
miLens system - Glaucoma, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
CompletedSmartlens, Inc.862025-02-192026-04-01
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Latanoprost-PPDS - Glaucoma, Ocular Hypertension (OH)
Phase 2CompletedMati Therapeutics Inc.572011-11-012013-09-26
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Latanoprost-PPDS - Glaucoma, Ocular Hypertension (OH)
Phase 2CompletedMati Therapeutics Inc.772011-11-012013-09-26

Narrower conditions

Ocular Hypertension (7)  ·  Glaucoma, Open-Angle (5)  ·  Glaucoma (4)  ·  Low Tension Glaucoma (1)

Broader conditions

Eye Diseases (7)  ·  Glaucoma (3)  ·  Optic Nerve Diseases (1)

Interventions

Bimatoprost (1)  ·  Travoprost (1)

Sponsors

Mati Therapeutics Inc. (2)  ·  Glaukos Corporation (1)  ·  Lumibird Medical (Quantel Medical, Ellex Medical, Optotek) (1)  ·  PolyActiva Pty Ltd (1)  ·  Smartlens, Inc. (1)  ·  YS Life Science Co., Ltd. (1)

Countries

United States (5)  ·  Australia (2)  ·  India (1)

Top investigators

Suzanne Cadden (2)